Futurity · Health

Neuromuscular Junction Failure Linked to Age-Related Muscle Weakness

Researchers have identified a breakdown in nerve-muscle communication as a key contributor to age-related muscle weakness, a condition known as sarcopenia.

A study by W. David Arnold and colleagues at the University of Missouri found that reduced levels of the protein NaV1.4 at the neuromuscular junction impair the signals between nerves and muscles, leading to weakness. This challenges the long-held assumption that this junction remains reliable with age.

The research, conducted in both human and animal models, suggests that this failure in communication is a significant factor in sarcopenia, which affects a large percentage of older adults.

The discovery offers a potential therapeutic target. Arnold's team collaborated with NMD Pharma to test an approach that partially inhibits the protein ClC-1. In an animal model, this inhibition improved muscle strength by making aging muscles more responsive to nerve signals.

While previous clinical studies by NMD Pharma have shown that targeting ClC-1 can improve muscle function in individuals with neuromuscular diseases like Charcot-Marie-Tooth disease, further research is needed to confirm its efficacy for sarcopenia in older adults.

AI-samenvatting op basis van de bron.